|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT! | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
March 01, 2005BREAKING NEWS: TYSABRI -SPECIAL WEBCAST AT 5:30 EST
'I WOULD LIKE TO THANK CHRIS UITHOVEN, PRESIDENT OF THE NATIONAL MULTIPLE SCLEROSIS SOCIETY, ARIZONA CHAPTER FOR THE FOLLOWING INFORMATION!" Stan Swartz, Publisher
This afternoon, March 1, 2005, at 5:30 EST, MS Learn Online will present a special webcast about the recent suspension of Tysabri. Presenters include: Dr. John Richert, Vice President of the Research and Clinical Programs Department of the National MS Society Dr. Aaron Miller, Chief Medical Officer of the National MS Society and Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis in New York City Dr. Al Sandrock, Vice President for Medical Research for Biogen IDEC. We will address common concerns and questions such as: Why was Tysabri suspended? What is PML? Is PML due to Avonex, Tysabri, or the combination of both? Is PML related to MS? Should I be tested? Are clinical trials being stopped? What does the FDA have to say about this? A written transcript of this webcast will be available on the MS Learn Online site by Thursday, March 3, 2005. **************************************** Click here today at 5:30 p.m. EST to go to webcast. This program will be continuously available on our web site after 5:30 p.m., March 1, 2005. For more general information about Tysabri, go to the FDA web site at http://www.fda.gov/cder/drug/infopage/ natalizumab/natalizumabQA_2_2005.htm. ***************************************** For more information or to access archived programs, please visit MS Learn Online on our national website, http://www.nationalmssociety.org/. Powered by List Builder |